| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $276.3M | +16.1% |
| Cost of Revenue | $71.9M | +2.1% |
| Gross Profit | $204.4M | +21.9% |
| R&D Expense | $90.1M | +11.8% |
| SG&A Expense | $54.9M | +2.3% |
| Pre-tax Income | -$89.1M | +3.8% |
| Income Tax | $1.3M | +59.4% |
| Net Income | -$90.4M | +3.2% |
| EPS (Basic) | -$0.77 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $248.5M | +13.7% |
| Short-term Investments | $73.9M | +517.4% |
| Accounts Receivable | $29.5M | +29.8% |
| Current Assets | $380.0M | +33.6% |
| Total Assets | $433.7M | +4.8% |
| Current Liabilities | $132.3M | +21.2% |
| Total Liabilities | $138.9M | +17.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.6M | +576.0% |
| Capital Expenditures | $1.3M | -64.8% |
| Investing Cash Flow | $9.3M | +110.4% |
| Financing Cash Flow | -$4.9M | -184.7% |
| Free Cash Flow | $24.4M | +370.1% |
| +8.3% |
| EPS (Diluted) | -$0.77 | +8.3% |
| Stockholders' Equity |
| $294.8M |
| -0.1% |